13F
中

VRTX VERTEX PHARMACEUTICALS INC

2026Q1 · CUSIP 92532F100 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
1,672
Δ holders QoQ
+18
Breadth percentile
Top 17%
Whale holders
336
Δ whales
-4
Inst. holding value
$100.5B
New positions
154
Closed positions
136
Price momentum (1Q)
-8.5%
Put / Call
30/34

Breadth history (34 quarters)

2018Q1: Δ+39 · h=670 2018Q2: Δ+5 · h=675 2018Q3: Δ+7 · h=682 2018Q4: Δ+8 · h=690 2019Q1: Δ+32 · h=722 2019Q2: Δ-15 · h=707 2019Q3: Δ-3 · h=704 2019Q4: Δ+96 · h=800 2020Q1: Δ+40 · h=840 2020Q2: Δ+99 · h=939 2020Q3: Δ-11 · h=928 2020Q4: Δ+21 · h=949 2021Q1: Δ+32 · h=981 2021Q2: Δ-27 · h=954 2021Q3: Δ-34 · h=920 2021Q4: Δ+104 · h=1024 2022Q1: Δ+36 · h=1060 2022Q2: Δ+30 · h=1090 2022Q3: Δ+14 · h=1104 2022Q4: Δ+98 · h=1202 2023Q1: Δ-10 · h=1192 2023Q2: Δ+72 · h=1264 2023Q3: Δ-1 · h=1263 2023Q4: Δ+159 · h=1422 2024Q1: Δ+56 · h=1478 2024Q2: Δ+50 · h=1528 2024Q3: Δ+2 · h=1530 2024Q4: Δ+16 · h=1546 2025Q1: Δ+51 · h=1597 2025Q2: Δ-51 · h=1546 2025Q3: Δ-41 · h=1505 2025Q4: Δ+149 · h=1654 2026Q1: Δ+18 · h=1672 2018Q1: holders=670 2018Q2: holders=675 2018Q3: holders=682 2018Q4: holders=690 2019Q1: holders=722 2019Q2: holders=707 2019Q3: holders=704 2019Q4: holders=800 2020Q1: holders=840 2020Q2: holders=939 2020Q3: holders=928 2020Q4: holders=949 2021Q1: holders=981 2021Q2: holders=954 2021Q3: holders=920 2021Q4: holders=1024 2022Q1: holders=1060 2022Q2: holders=1090 2022Q3: holders=1104 2022Q4: holders=1202 2023Q1: holders=1192 2023Q2: holders=1264 2023Q3: holders=1263 2023Q4: holders=1422 2024Q1: holders=1478 2024Q2: holders=1528 2024Q3: holders=1530 2024Q4: holders=1546 2025Q1: holders=1597 2025Q2: holders=1546 2025Q3: holders=1505 2025Q4: holders=1654 2026Q1: holders=1672 -159 -79.5 +0 +79.5 +159 60311801756 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 18 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 17% — —
2025Q4 Top 2% -8.5% —
2025Q1 Top 2% -11.3% -1.5%
2024Q2 Top 3% +1.4% -1.2%
2024Q1 Top 3% +9.6% +4.6%
2023Q4 Top 2% +5.5% +15.6%
2023Q2 Top 1% +7.7% +24.1%
2022Q4 Top 2% +16.2% +18.1%

Options Sentiment

Put holders
30
QoQ: -1
Call holders
34
QoQ: +3

See methodology →

Fundamentals

PE (TTM)
28.3
EPS (TTM)
$16.85
EPS YoY
—
Revenue (TTM)
$12.2B
Revenue YoY
+10.1%
Quarterly Revenue & EPS (4Y)
2022-06-30: $2.2B 2022-09-30: $2.3B 2022-12-31: $2.3B 2023-03-31: $2.4B 2023-06-30: $2.5B 2023-09-30: $2.5B 2023-12-31: $2.5B 2024-03-31: $2.7B 2024-06-30: $2.6B 2024-09-30: $2.8B 2024-12-31: $2.9B 2025-03-31: $2.8B 2025-06-30: $3.0B 2025-09-30: $3.1B 2025-12-31: $3.2B 2026-03-31: $3.0B 2022-06-30: EPS 3.13 2022-09-30: EPS 3.59 2022-12-31: EPS 3.14 2023-03-31: EPS 2.69 2023-06-30: EPS 3.52 2023-09-30: EPS 3.97 2023-12-31: EPS 3.71 2024-03-31: EPS 4.21 2024-06-30: EPS -13.92 2024-09-30: EPS 4.01 2024-12-31: EPS 3.62 2025-03-31: EPS 2.49 2025-06-30: EPS 3.99 2025-09-30: EPS 4.20 2025-12-31: EPS 4.64 2026-03-31: EPS 4.02 0B 1.6B 3.2B $B -15.31 -5.10 5.10 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 28 2023-03-31: PE 27.22023-06-30: PE 26.52023-09-30: PE 25.82023-12-31: PE 30.42024-03-31: PE 28.92025-06-30: PE 27.82025-09-30: PE 30.62025-12-31: PE 32.12026-03-31: PE 25.9 23 28 34 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)